Home/Filings/4/0001181431-11-002761
4//SEC Filing

Qian Changgeng 4

Accession 0001181431-11-002761

CIK 0001108205other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 3:58 PM ET

Size

7.6 KB

Accession

0001181431-11-002761

Insider Transaction Report

Form 4
Period: 2011-01-07
Qian Changgeng
VP, Research & Preclinical Dev
Transactions
  • Award

    Qualified stock option (right to buy)

    2011-01-07+93,49293,492 total
    Exercise: $2.15Exp: 2021-01-07Common stock (93,492 underlying)
  • Award

    Non-qualified stock option (right to buy)

    2011-01-07+31,50831,508 total
    Exercise: $2.15Exp: 2021-01-07Common stock (31,508 underlying)
Footnotes (1)
  • [F1]Options in the aggregate will vest 25% on the one-year anniversary grant date, or January 7, 2012. Remaining options will vest at 6.25% each successive three-month period, with non-qualified options vesting first. Options will be fully vested four years from the grant date.

Issuer

CURIS INC

CIK 0001108205

Entity typeother

Related Parties

1
  • filerCIK 0001402196

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 3:58 PM ET
Size
7.6 KB